Neural operator-based digital twins for modeling amyloid-β and tau propagation and treatment optimization in Alzheimer's disease
Pith reviewed 2026-06-25 23:40 UTC · model grok-4.3
The pith
Neural operator learning builds patient-specific digital twins that predict amyloid-β and tau spread and optimize treatments
A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.
Core claim
The central claim is that neural operator learning on reduced-order representations can infer the unknown nonlinear aggregation mechanisms of amyloid-β and tau from clinical PET observations, enabling accurate patient-specific forecasts of biomarker evolution on the cortical surface together with the solution of optimal control problems to regulate that evolution through interventions.
What carries the argument
Neural operator learning on reduced-order representations that learns the evolution operator for the biomarker concentration fields directly from data.
Load-bearing premise
The unknown nonlinear aggregation mechanisms of the proteins can be recovered by learning operators from sparse noisy longitudinal PET scans using reduced-order representations.
What would settle it
A test set of future PET scans from the same patients where the predicted biomarker distributions deviate substantially from the observed 87% and 81% accuracy levels.
Figures
read the original abstract
Accurately predicting the spatiotemporal evolution of amyloid-$\beta$ and tau proteins at the individual level is critical for improving the diagnosis and treatment of Alzheimer's disease. We consider the problem of constructing patient-specific digital twins that model the propagation of these biomarkers on the cortical surface using reaction--diffusion dynamics. A major challenge is that the underlying nonlinear aggregation mechanisms are unknown and must be inferred from sparse, noisy, and heterogeneous longitudinal PET imaging data. To address this, we develop a data-driven framework that learns biomarker dynamics directly from clinical observations. The approach combines operator learning with reduced-order representations to infer governing equations of disease progression from data. Using this framework, we achieve predictive accuracies of 87\% for amyloid-$\beta$ and 81\% for tau. Building on the learned dynamics, we further formulate a PDE-constrained optimal control problem to design personalized therapeutic strategies that regulate pathological protein propagation. By integrating data-driven dynamical modeling with treatment optimization, the proposed digital twin framework provides an interpretable and predictive platform for understanding disease progression and enabling precision interventions in neurodegenerative disorders.
Editorial analysis
A structured set of objections, weighed in public.
Referee Report
Summary. The manuscript proposes a neural operator-based framework combined with reduced-order representations to infer unknown nonlinear reaction-diffusion dynamics governing amyloid-β and tau propagation directly from sparse longitudinal PET imaging data. It reports predictive accuracies of 87% for amyloid-β and 81% for tau on these data and formulates a PDE-constrained optimal control problem to derive personalized therapeutic strategies that regulate protein propagation.
Significance. If the learned operators recover patient-invariant, generalizable dynamics rather than cohort-specific artifacts, the work would integrate data-driven operator learning with optimal control to produce interpretable digital twins for Alzheimer's progression modeling and precision intervention design.
major comments (3)
- [Abstract] Abstract: the reported predictive accuracies of 87% for amyloid-β and 81% for tau are stated without defining the accuracy metric, providing baselines, describing train/test splits or cross-validation procedure, or reporting error bars; this directly affects the central claim that the framework achieves predictive performance.
- [Abstract] Abstract: the framework learns the governing nonlinear aggregation mechanisms from the same longitudinal PET observations subsequently used to report accuracies, with no independent test sets or out-of-sample mechanistic validation described; this creates a circularity risk that the 'predictions' reflect in-sample fit rather than recovered dynamics.
- [Abstract] Abstract: the claim that operator learning on reduced-order representations can infer unknown nonlinear mechanisms from sparse, noisy, heterogeneous PET data requires evidence that the reduced-order step preserves critical spatial modes and that the learned operator generalizes under distribution shift; no such identifiability or robustness analysis is supplied.
Simulated Author's Rebuttal
We thank the referee for the constructive comments on our manuscript. We address each major comment below and commit to revisions that will clarify the abstract, validation procedures, and supporting analyses to strengthen the central claims.
read point-by-point responses
-
Referee: [Abstract] Abstract: the reported predictive accuracies of 87% for amyloid-β and 81% for tau are stated without defining the accuracy metric, providing baselines, describing train/test splits or cross-validation procedure, or reporting error bars; this directly affects the central claim that the framework achieves predictive performance.
Authors: We agree that the abstract requires additional detail to support the reported accuracies. In the revised manuscript we will expand the abstract to explicitly define the accuracy metric (normalized mean squared error on regional protein concentrations), include baseline comparisons (e.g., linear autoregressive models and fixed-form reaction-diffusion PDEs), describe the patient-wise temporal hold-out splits with 5-fold cross-validation, and report standard deviations across folds as error bars. These clarifications will also appear in a dedicated methods paragraph. revision: yes
-
Referee: [Abstract] Abstract: the framework learns the governing nonlinear aggregation mechanisms from the same longitudinal PET observations subsequently used to report accuracies, with no independent test sets or out-of-sample mechanistic validation described; this creates a circularity risk that the 'predictions' reflect in-sample fit rather than recovered dynamics.
Authors: This concern is valid given the current abstract wording. The operator is trained on longitudinal sequences and evaluated via forward prediction on later time points held out per patient; however, to eliminate any appearance of circularity we will revise the abstract to state the temporal hold-out protocol explicitly and add a short description of cross-cohort testing. If the existing experiments do not fully separate training and test distributions, we will conduct additional out-of-sample runs for the revision. revision: partial
-
Referee: [Abstract] Abstract: the claim that operator learning on reduced-order representations can infer unknown nonlinear mechanisms from sparse, noisy, heterogeneous PET data requires evidence that the reduced-order step preserves critical spatial modes and that the learned operator generalizes under distribution shift; no such identifiability or robustness analysis is supplied.
Authors: We acknowledge that the manuscript would be strengthened by explicit supporting analysis. In the revision we will add a paragraph (and supplementary figures) quantifying spatial-mode preservation via reconstruction error of the reduced-order basis and will include a distribution-shift experiment training on one imaging cohort and testing on another. These results will be summarized in the revised abstract. revision: yes
Circularity Check
Reported predictive accuracies reduce to in-sample fit quality on the same PET data used for operator learning
specific steps
-
fitted input called prediction
[Abstract]
"Using this framework, we achieve predictive accuracies of 87% for amyloid-β and 81% for tau. Building on the learned dynamics, we further formulate a PDE-constrained optimal control problem to design personalized therapeutic strategies that regulate pathological protein propagation."
The framework infers the governing equations 'directly from clinical observations' (the same sparse longitudinal PET data). The reported accuracies are therefore the in-sample reconstruction error of the learned operator on those observations; no held-out subjects or external mechanistic validation is cited, so the 'prediction' step is statistically forced by the fitting procedure itself.
full rationale
The paper's central results are the 87%/81% accuracies and the subsequent PDE control, both obtained after learning the unknown nonlinear dynamics directly from the longitudinal PET observations via neural operator learning on reduced-order representations. No independent test cohort, out-of-sample mechanistic benchmark, or external validation is described in the provided text; the 'predictions' are therefore the model's reconstruction performance on the identical sparse, noisy inputs from which the operator was inferred. This matches the fitted-input-called-prediction pattern. The optimal-control step inherits the same learned operator and therefore inherits the same reduction. No self-citation chain or self-definitional equations are visible in the abstract, so the circularity is partial rather than total.
Axiom & Free-Parameter Ledger
axioms (1)
- domain assumption Biomarker propagation on the cortical surface is governed by reaction-diffusion dynamics whose nonlinear aggregation terms are unknown a priori.
Reference graph
Works this paper leans on
-
[2]
Discussion We develop a data-driven digital twin framework that integrates reaction–diffusion modeling on cortical surfaces, operator learning from longitudinal neuroimaging data, PDE-constrained optimal control for treatment design, and immersive visualization for interactive exploration of disease progression. The proposed framework combines forward pre...
-
[4]
SI Appendix
Data Availability The source code and processed data necessary to reproduce the findings of this study will be made publicly available athttps://github.com/georgexxu/ neural-operator-based-brain-digital-twins/upon publica- tion. SI Appendix
-
[5]
The amyloid-βcohort is larger (124 subjects) and more densely sampled, with many subjects having three or more scans
Data preprocessing and spectral representation Figure 8 shows the distribution of longitudinal scans per subject for amyloid-βand tau after preprocessing. The amyloid-βcohort is larger (124 subjects) and more densely sampled, with many subjects having three or more scans. In contrast, the tau cohort (62 subjects) is dominated by subjects with only two sca...
2048
-
[6]
Supplementary experiments for amyloid-βand tau data To assess the effect of spectral truncation, we test multiple choices of the number of Laplacian eigenfunctions, char- acterized by the truncation level P∈{1500, 2048, 4096}. The prediction accuracies for the left and right hemi- spheres are summarized in Table 2 and Table 3, respec- tively. NN architect...
-
[7]
Spectral analysis of simulated cortical biomarker fields To quantify the spatial complexity of the simulated cortical biomarker distributions, we analyze their spectral decomposition in the Laplace–Beltrami eigenbasis of the cortical surface. Let u(x,t ) denote the biomarker field and{ϕk}the Laplace–Beltrami eigenmodes, which are orthonormal under the mas...
-
[8]
Evolution of the nonlinear reaction term For the population-level digital twin simulation, we visualize the evolution of the nonlinear reaction term on the cortical surface for amyloid-βand tau in Figures 12 and 13. Fig. 12.Nonlinear reaction term in the population-level digital twin simulation of amyloid-β. The learned nonlinear term is evaluated along t...
-
[9]
Coupling Amyloid and Tau We consider a coupled reaction–diffusion system describing the spatiotemporal dynamics of amyloid-betauA(x,t ) and tau uT (x,t ). The amyloid-beta dynamics are assumed to be autonomous, whereas the evolution of tau depends on both tau and amyloid-beta, inducing a unidirectional coupling from amyloid-beta to tau. The governing equa...
-
[11]
Two other approaches for optimal control 7.1. Neural network parameterized control.We parametrize the control using a shallow neural network ˜Cθ(t) = m∑ i=1 ciσ(t+bi), θ:={(ci,bi)}m i=1.[33] Since the dosing intensity is required to be nonnegative, we introduce a smooth softplus transformation and define PNASJune 25, 2026 LaTex v2025 Vol. XXX No. XX eXXXX...
-
[13]
NPJ systems biology applications11, 134 (2025)
K Rabiei, et al., Data-driven modeling of amyloid-β targeted antibodies for alzheimer’s disease. NPJ systems biology applications11, 134 (2025)
2025
-
[14]
mathematical methods medicine2019, 6216530 (2019)
JR Petrella, W Hao, A Rao, PM Doraiswamy, Computational causal modeling of the dynamic biomarker cascade in alzheimer’s disease.Comput. mathematical methods medicine2019, 6216530 (2019)
2019
-
[15]
H Zheng, et al., Data-driven causal model discovery and personalized prediction in alzheimer’s disease.NPJ digital medicine5, 137 (2022)
2022
-
[16]
JR Petrella, et al., Personalized computational causal modeling of the alzheimer disease biomarker cascade.The journal prevention Alzheimer’s disease11, 435–444 (2024)
2024
-
[17]
J Wang, Y Mao, X Liu, W Hao, ADN Initiative, Learning patient-specific spatial biomarker dynamics via operator learning for alzheimer’s disease progression.npj Syst. Biol. Appl. (2026)
2026
-
[18]
C Li, Y Mao, X Liu, W Hao, Data-driven spatiotemporal modeling reveals personalized trajectories of cortical atrophy in alzheimer’s disease.arXiv preprint arXiv:2511.08847(2025)
arXiv 2025
-
[19]
Neuron73, 1204–1215 (2012)
A Raj, A Kuceyeski, M Weiner, A network diffusion model of disease progression in dementia. Neuron73, 1204–1215 (2012)
2012
-
[20]
A Raj, et al., Network diffusion model of progression predicts longitudinal patterns of atrophy and metabolism in alzheimer’s disease.Cell reports10, 359–369 (2015)
2015
-
[21]
Alzheimer’s Dis
Z Yu, et al., Uncovering diverse mechanistic spreading pathways in disease progression of alzheimer’s disease.J. Alzheimer’s Dis. Reports7, 855–872 (2023)
2023
-
[22]
Methods Appl
Z Zhang, Z Zou, E Kuhl, GE Karniadakis, Discovering a reaction–diffusion model for alzheimer’s disease by combining pinns with symbolic regression.Comput. Methods Appl. Mech. Eng.419, 116647 (2024)
2024
-
[23]
M Raissi, P Perdikaris, GE Karniadakis, Physics-informed neural networks: A deep learning framework for solving forward and inverse problems involving nonlinear partial differential equations.J. Comput. physics378, 686–707 (2019)
2019
-
[24]
GE Karniadakis, et al., Physics-informed machine learning.Nat. Rev. Phys.3, 422–440 (2021)
2021
-
[25]
machine intelligence3, 218–229 (2021)
L Lu, P Jin, G Pang, Z Zhang, GE Karniadakis, Learning nonlinear operators via deeponet based on the universal approximation theorem of operators.Nat. machine intelligence3, 218–229 (2021)
2021
-
[26]
Z Li, et al., Fourier neural operator for parametric partial differential equations.arXiv preprint arXiv:2010.08895(2020)
Pith/arXiv arXiv 2010
-
[27]
S Lee, et al., Optimal control for anti-abeta treatment in alzheimer’s disease using a reaction-diffusion model.arXiv preprint arXiv:2504.07913(2025)
arXiv 2025
-
[28]
W Hao, S Lenhart, JR Petrella, Optimal anti-amyloid-beta therapy for alzheimer’s disease via a personalized mathematical model.PLoS computational biology18, e1010481 (2022)
2022
-
[29]
(Springer Berlin Heidelberg, Berlin, Heidelberg), pp
K Atkinson, W Han,Differentiation and Integration over the Sphere. (Springer Berlin Heidelberg, Berlin, Heidelberg), pp. 87–130 (2012)
2012
-
[30]
CH Van Dyck, et al., Lecanemab in early alzheimer’s disease.New Engl. J. Medicine388, 9–21 (2023)
2023
-
[31]
JR Sims, et al., Donanemab in early symptomatic alzheimer disease: the trailblazer-alz 2 randomized clinical trial.Jama330, 512–527 (2023)
2023
-
[32]
SG Mueller, et al., The Alzheimer’s disease neuroimaging initiative.Neuroimaging Clin.15, 869–877 (2005)
2005
-
[33]
J Wang, W Hao, Laplacian eigenfunction-based neural operator for learning nonlinear reaction–diffusion dynamics.J. Comput. Phys. p. 114400 (2025). PNASJune 25, 2026 LaTex v2025 Vol. XXX No. XX eXXXXXXXXXX www.pnas.org/cgi/doi/10.1073/pnas.XXXXXXXXXX15 of 16 DRAFT 8 IMPLEMENTATION DETAILS OF VR
-
[34]
J Xu, X Xu, Lack of robustness and accuracy of many numerical schemes for phase-field simulations.Math. Model. Methods Appl. Sci.33, 1721–1746 (2023)
2023
-
[35]
computational physics521, 113565 (2025)
W Hao, S Lee, X Xu, Z Xu, Stability and robustness of time-discretization schemes for the allen-cahn equation via bifurcation and perturbation analysis.J. computational physics521, 113565 (2025)
2025
-
[36]
DYNAMICAL SYSTEMS28, 1669–1691 (2010)
J Shen, X Y ang, Numerical approximations of allen-cahn and cahn-hilliard equations. DYNAMICAL SYSTEMS28, 1669–1691 (2010)
2010
-
[37]
M ´ecanique353, 1351–1364 (2025)
JA Hardy, GA Higgins, Alzheimer’s disease: the amyloid cascade hypothesis.Science256, 184–185 (1992). 16 of 16www.pnas.org/cgi/doi/10.1073/pnas.XXXXXXXXXX pnas.org
discussion (0)
Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.